Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px
Document › Details

Kurma Partners. (4/13/21). "Press Release: Jean-François Rivassou Joins Kurma Partners as Partner". Paris.

Organisations Organisation Kurma Partners (Kurma Life Sciences Partners)
  Group Eurazeo (Group)
  Organisation 2 ISAI Gestion
  Group ISAI (Group)
Products Product venture capital
Persons Person Rivassou, Jean-François (Kurma Partners 202104– Partner before ISAI Gestion + Adenclassifieds + Banexi Ventures)
  Person 2 Merigeau, Nicolas (NewCap 201502)

Kurma Partners, a leading European venture capital company in the field of Life Sciences based in Paris and Munich with nearly 500 million euros under management, today announced the appointment of Jean-François Rivassou as Partner.

Jean-François Rivassou, 45, has been appointed as Partner to further support Kurma Partners life sciences portfolio companies in their late-stage development.

Jean-François was previously in charge of growth and private equity investments at ISAI Gestion, a Paris based tech fund. From 2006 to 2012, he was Head of M&A and Business Development, and a member of Adenclassifieds’ management committee, a digital company listed on Euronext Paris. Prior Adenclassifieds, he worked as an investment manager at Banexi Ventures Partners, a BNP Paribas backed VC fund, where he was responsible for biotech and medtech investments. Jean-François started his career at Genset, a Euronext and Nasdaq listed genomics company, in the group’s Singaporean subsidiary. Jean-François graduated from the Ecole Nationale Supérieure des Mines de Paris, a leading generalist engineering school, where he specialized in Biotechnology.

In a context of increasing maturity of the European Life Sciences ecosystem, the appointment of Jean-François illustrates Kurma Partners’ ambition to strengthen, in an integrated manner, its expertise in the more advanced phases of development of its portfolio companies.

About Kurma Partners :

Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).


Nicolas Merigeau
Medias Relations
Phone nb.: +33 (0)1 44 71 94 98

Record changed: 2022-02-05


Picture [iito] Männer Ballett 650x100px

More documents for Eurazeo (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top